Latest filing published 02 Apr 2026 for Bristol Myers Squibb Co, €1.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of David Elkins V across 2 companies, led by Bristol Myers Squibb Co and Tapestry, Inc. Between 1 August 2021 and 1 April 2026, the trades on record add up to 20 filings.
On the market, this insider has only sold: 5 sales, €8.3M in total. Outside the open market, there are 4 share grants and 11 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 2 April 2026 with an open-market sale (€1.4M) in Bristol Myers Squibb Co. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations